Body composition, metabolic syndrome and insulin resistance in type 1 diabetes mellitus;Composição corporal, síndrome metabólica e resistência insulínica no diabetes melito tipo 1

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 55, Issue 3, 2011, Pages 189-193

  Momesso, Denise Prado ^a   Bussade, Isabela ^a,b   Balarini Lima, Giovanna A ^a   Fonseca, Leniane Pereira Coelho ^a   Russo, Luis Augusto Tavares ^c   Kupfer, Rosane ^a  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c Center for Basic and Clinical Research   (Brazil)

Author keywords

Body composition; Insulin resistance; Metabolic syndrome; Type 1 diabetes

Indexed keywords

ADIPOSE TISSUE; ADULT; ARTICLE; BODY COMPOSITION; CASE CONTROL STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY; RISK FACTOR;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; RISK FACTORS;

EID: 79958254832     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302011000300003     Document Type: Article

References (27)

1. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Ann Rev Med. 1993;44:121-131.
2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation. European group for the study of insulin resistance (EGIR). Diabet Med. 1999;16:442-443.
3. Laaksonen DE, Lakka HM, Niskanen L, Kaplan GA, Salonen J T, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156:1070-1077.
4. Picon PX, Zanatta CM, Gerchman F, Zelmanowitz T, Gross JL, Ca-nani LH. Analysis of the criteria used for the definition of metabolic syndrome in patients with type 2 diabetes. Arq Bras Endocri-nol Metabol. 2006;50:264-270.
5. Isomaa B, Almgren P, Tiinamaija T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683-689.
6. Haffner SM. The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol. 2006;97:3-11.
7. Teupe B, Bergis K. Epidemiological evidence for "double diabetes". Lancet. 1991;337:361-362.
8. Thorn LM, Forsblom C, Fegerudd J, Thomas MC, Petterson-Fer-nholm K, Saraheimo M, et al. Metabolic syndrome in type 1 diabetes. Diabetes Care. 2005;28:2019-2024.
9. Dib SA. Insulin resistance and metabolic syndrome in type 1 diabetes. Arq Bras Endocrinol Metabol. 2006;50:250-263.
10. Pambianco G, Costacou T, Orchard TJ. The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome and their components and estimated glucose disposal rate. Diabetes Care. 2007;30:1248-1254.
11. Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care. 2007;30:707-712.
12. Davis TME, Bruce DG, Davis WA. Prevalence and prognostic implications of the metabolic syndrome in community-based patients with type 1 diabetes: the Fremantle Diabetes Study. Diabetes Res Clin Pract. 2007;78:412-417.
13. Santos CE, Schrank Y, Kupfer R. Critical analyses of WHO, IDF and NCEP criteria for metabolic syndrome among patients with type 1 diabetes mellitus. Arq Bras Endocrinol Metab. 2009;53:1096-1102.
14. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complication of obesity. J Clin Endocrinol Metab. 1982;54:254-260.
15. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S. Contribution of intra--abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36:54-59.
16. Ribeiro Filho F F, Mariosa LS, Ferreira SRG, Zanella M T. Gordura visceral e síndrome metabólica: mais do que uma simples associação. Arq Bras Endocrinol Metabol. 2006;50:230-238.
17. Mazess RB, Barden HS, Bisek J P, Hanson J. Dual-X-ray-absorptiometry for total body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51:1106-12.
18. Prior BM, Cureton KJ, Modlesky CM, Evans EM, Sloniger MA, Sa-unders M, et al. In vivo validation of whole body composition estimates from dual-energy X-ray absorptiometry. J Appl Physiol. 1997;83:623-630.
19. Clasey JL, Bouchard C, Teates CD. The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes Res. 1999;7:256-264.
20. Park YW, Hemsfeld SB, Gallagher D. Are dual-energy X-ray absorptiometry regional estimates associated with visceral adipose tissue mass? Int J Obes Relat Metab Disord. 2002;26:978-983.
21. Norcross J, Van Loan MD. Validation of fan beam dual energy X-ray absorptiometry for body composition assessment in adults aged 18-45 years. Br J Sports Med. 2004;38:472-476.
22. Lee CC, Glickman SG, Dengel DR, Brown MD, Supiano MA. Abdominal adiposity assessed by dual energy X-ray absorptiometry provides a sex-independent predictor of insulin sensitivity in older adults. J Gerontol A Biol Sci Med Sci. 2005;60:872-878.
23. Friedwald W T, Levy RI, Fredrickson DS. Estimation of the concentration of low lipoprotein colesterol in plasma without use of preparative centrifugation. Clin Chem. 1972;18:499-502.
24. Williams K, Erbey J, Becker D, Arslanian S, Orchard T. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49:626-632.
25. DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a proeminent feature of insulin-dependent diabetes. Diabetes. 1982;31:795-801.
26. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viberti G. Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet. 1993;342:883-887.
27. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY-Z, Smithline Kinder L, et al. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up from the Pittsburgh Epidemiology of Diabetes Complications study. Diabetes Care. 2003;26:1374-1379.